Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony Antoniou

Showing results (111-120 of 162) with videos related to

Pageof 17
Sort By:
CMAJ Open|September 22, 2015
Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort studyTony Antoniou, Erin M Macdonald, Simon Hollands, et al.
BMC Musculoskeletal Disorders|May 24, 2018
A population-based study of the risk of osteoporosis and fracture with dutasteride and finasterideTony Antoniou, Erin M Macdonald, Zhan Yao, et al.
The International Journal on Drug Policy|February 6, 2022
Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, CanadaSamantha Young, Gillian Kolla, Daniel McCormack, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|June 15, 2023
The epidemiology of benzodiazepine-related toxicity in Ontario, Canada: a population-based descriptive studyTonya J Campbell, Siyu Men, Dana Shearer, et al.
The International Journal on Drug Policy|March 10, 2022
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysisSophie A Kitchen, Tonya J Campbell, Siyu Men, et al.
HIV Clinical Trials|December 23, 2011
Four-year follow-up of polyalkylimide gel use for the treatment of HIV-associated lipoatrophyMona R Loutfy, Jason Brunetta, Colin Kovacs, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|August 18, 2025
Trends in the dispensing of opioids for pain and concurrent benzodiazepine use among First Nations People in Ontario, Canada, from 2013 to 2021Alice Holton, Tianru Wang, Bisola Hamzat, et al.
AIDS (London, England)|May 16, 2007
Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patientsMona R Loutfy, Janet M Raboud, Tony Antoniou, et al.
JAMA Network Open|June 30, 2025
Retention in Opioid Agonist Therapy Among First Nations PeopleAlice Holton, Bisola Hamzat, Daniel McCormack, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 5, 2023
Impact of a Publicly-Funded Pharmacare Program on Prescription Stimulant use Among Children and Youth: A Population-Based Observational Natural ExperimentTony Antoniou, Daniel McCormack, Sophie Kitchen, et al.
Pageof 17

Showing results (111-120 of 162) with videos related to

Sort By:
Pageof 17
CMAJ Open|September 22, 2015
Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort studyTony Antoniou, Erin M Macdonald, Simon Hollands, et al.
BMC Musculoskeletal Disorders|May 24, 2018
A population-based study of the risk of osteoporosis and fracture with dutasteride and finasterideTony Antoniou, Erin M Macdonald, Zhan Yao, et al.
The International Journal on Drug Policy|February 6, 2022
Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, CanadaSamantha Young, Gillian Kolla, Daniel McCormack, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|June 15, 2023
The epidemiology of benzodiazepine-related toxicity in Ontario, Canada: a population-based descriptive studyTonya J Campbell, Siyu Men, Dana Shearer, et al.
The International Journal on Drug Policy|March 10, 2022
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysisSophie A Kitchen, Tonya J Campbell, Siyu Men, et al.
HIV Clinical Trials|December 23, 2011
Four-year follow-up of polyalkylimide gel use for the treatment of HIV-associated lipoatrophyMona R Loutfy, Jason Brunetta, Colin Kovacs, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|August 18, 2025
Trends in the dispensing of opioids for pain and concurrent benzodiazepine use among First Nations People in Ontario, Canada, from 2013 to 2021Alice Holton, Tianru Wang, Bisola Hamzat, et al.
AIDS (London, England)|May 16, 2007
Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patientsMona R Loutfy, Janet M Raboud, Tony Antoniou, et al.
JAMA Network Open|June 30, 2025
Retention in Opioid Agonist Therapy Among First Nations PeopleAlice Holton, Bisola Hamzat, Daniel McCormack, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 5, 2023
Impact of a Publicly-Funded Pharmacare Program on Prescription Stimulant use Among Children and Youth: A Population-Based Observational Natural ExperimentTony Antoniou, Daniel McCormack, Sophie Kitchen, et al.
Pageof 17